Natixis Advisors LLC Has $1.29 Million Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Natixis Advisors LLC increased its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,711 shares of the real estate investment trust’s stock after purchasing an additional 331 shares during the period. Natixis Advisors LLC’s holdings in Omega Healthcare Investors were worth $1,291,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Lazard Asset Management LLC increased its position in shares of Omega Healthcare Investors by 259.1% during the first quarter. Lazard Asset Management LLC now owns 4,043 shares of the real estate investment trust’s stock valued at $128,000 after purchasing an additional 2,917 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in Omega Healthcare Investors by 2.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 133,166 shares of the real estate investment trust’s stock valued at $4,218,000 after buying an additional 3,466 shares during the period. Bayesian Capital Management LP acquired a new position in shares of Omega Healthcare Investors in the 1st quarter valued at $329,000. Tidal Investments LLC lifted its holdings in shares of Omega Healthcare Investors by 2.5% during the 1st quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock worth $454,000 after acquiring an additional 348 shares during the period. Finally, Coppell Advisory Solutions Corp. acquired a new stake in shares of Omega Healthcare Investors during the 1st quarter valued at about $319,000. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Price Performance

Omega Healthcare Investors stock opened at $40.77 on Wednesday. The stock has a market capitalization of $11.01 billion, a price-to-earnings ratio of 29.98, a PEG ratio of 1.25 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42. The stock’s 50 day moving average price is $40.61 and its two-hundred day moving average price is $37.19. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.57%. Omega Healthcare Investors’s dividend payout ratio is presently 197.06%.

Insider Activity at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Truist Financial raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Scotiabank lifted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Royal Bank of Canada boosted their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday, November 11th. BMO Capital Markets increased their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Finally, BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.